Supplement: Cardiology and Therapy

Overview

Journal Cardiol Ther

Specialty Cardiology & Vascular Diseases

Date 2015 Jun 20

PMID 26088277

Authors

Alejandro De La Sierra

Affiliations

Soon will be listed here.

References

Banegas J, Ruilope L, De La Sierra A, de la Cruz J, Gorostidi M, Segura J . High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014; 35(46):3304-12. DOI: 10.1093/eurheartj/ehu016. View

OBrien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G . European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013; 31(9):1731-68. DOI: 10.1097/HJH.0b013e328363e964. View

Parati G, Ochoa J, Lombardi C, Bilo G . Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013; 10(3):143-55. DOI: 10.1038/nrcardio.2013.1. View

Izzo Jr J, Chrysant S, Kereiakes D, Littlejohn Iii T, Oparil S, Melino M . 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy. J Clin Hypertens (Greenwich). 2011; 13(12):873-80. PMC: 8108998. DOI: 10.1111/j.1751-7176.2011.00544.x. View

Mori H, Yamamoto H, Ukai H, Yuasa S, Nakajima K, Mikawa T . Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study. Hypertens Res. 2012; 36(3):202-7. DOI: 10.1038/hr.2012.142. View

Mancia G, Parati G . Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004; 22(3):435-45. DOI: 10.1097/00004872-200403000-00001. View

Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Hiramatsu K . Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks. J Hum Hypertens. 2013; 27(12):721-8. PMC: 3831295. DOI: 10.1038/jhh.2013.68. View

Matsui Y, ORourke M, Hoshide S, Ishikawa J, Shimada K, Kario K . Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and.... Hypertension. 2012; 59(6):1132-8. DOI: 10.1161/HYPERTENSIONAHA.111.189217. View

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M . 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31(7):1281-357. DOI: 10.1097/01.hjh.0000431740.32696.cc. View

10.

Vinyoles E, Felip A, Pujol E, De La Sierra A, Dura R, Hernandez Del Rey R . Clinical characteristics of isolated clinic hypertension. J Hypertens. 2008; 26(3):438-45. DOI: 10.1097/HJH.0b013e3282f3150b. View